Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets

Yiran Liang(Qilu Hospital of Shandong University), Qifeng Yang(Qilu Hospital of Shandong University), Hanwen Zhang(Dongguan People’s Hospital), Xiaojin Song(Qilu Hospital of Shandong University)
Seminars in Cancer Biology
August 14, 2019
10.1016/j.semcancer.2019.08.012
Cited by 1,028

Related Papers

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
|Journal of Cellular Physiology|2018|301
Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell
|Chemical Science|2020|245
Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota
|Microbiome|2019|227